Entera Bio (ENTX) Institutional Ownership → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ENTX Stock Alerts $2.25 -0.06 (-2.60%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Entera Bio (NASDAQ:ENTX)CurrentInstitutional OwnershipPercentage14.11%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$36.81KNumber ofInstitutional Sellers(last 12 months)0 Get ENTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Entera Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENTX Institutional Buying and Selling by Quarter Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Entera Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC22,040$37K0.0%N/A0.000% 2/14/2023 RA Capital Management L.P.295,966$216K0.0%-85.8%1.028% 11/14/2022 RA Capital Management L.P.2,082,372$2.17M0.0%-11.5%7.229% 1/31/2022Altium Wealth Management LLC11,830$33K0.0%N/A0.050% 1/28/2022 ARK Investment Management LLC690,922$1.95M0.0%+1.2%2.915% 8/17/2021 Knoll Capital Management LLC2,484,275$14.86M7.8%+38.7%10.482% 8/16/2021 RA Capital Management L.P.2,353,000$14.07M0.2%N/A9.928% 8/13/2021 Geode Capital Management LLC17,597$105K0.0%N/A0.074% 8/11/2021Susquehanna Fundamental Investments LLC14,400$86K0.0%N/A0.061% 6/14/2021 Knoll Capital Management LLC1,791,363$6.83M4.4%+2.9%7.558% 5/18/2021 Millennium Management LLC38,611$147K0.0%N/A0.163% 5/14/2021 XTX Topco Ltd11,559$44K0.0%N/A0.101% 5/13/2021 Renaissance Technologies LLC120,407$459K0.0%+66.8%1.053% 2/24/2021 Virtu Financial LLC31,314$34K0.0%N/A0.274% 2/10/2021 Renaissance Technologies LLC72,186$78K0.0%N/A0.632% 10/20/2020 Wedbush Securities Inc.121,616$151K0.0%+305.3%1.064% 8/10/2020 Phoenix Holdings Ltd.37,400$66K0.0%-46.1%0.000% 7/16/2020 Wedbush Securities Inc.30,008$55K0.0%N/A0.000% 5/20/2020 Phoenix Holdings Ltd.69,355$138K0.0%N/A0.607% (Data available from 1/1/2016 forward) ENTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Entera Bio shares: RA Capital Management L.P. ($216K), Virtu Financial LLC ($37K).Learn more on ENTX's institutional investors. What percentage of Entera Bio stock is owned by institutional investors? 14.11% of Entera Bio stock is owned by institutional investors. Learn more on ENTX's institutional investor holdings. Which institutional investors have been buying Entera Bio stock? The following institutional investors have purchased Entera Bio stock in the last 24 months: Virtu Financial LLC ($22.04K). How much institutional buying is happening at Entera Bio? Institutional investors have bought a total of 22,040 shares in the last 24 months. This purchase volume represents approximately $36.81K in transactions. Which Entera Bio major shareholders have been selling company stock? The following institutional investors have sold Entera Bio stock in the last 24 months: RA Capital Management L.P. ($2.06M). How much institutional selling is happening at Entera Bio? Institutional investors have sold a total of 2,057,034 shares in the last 24 months. This volume of shares sold represents approximately $1.59M in transactions. Related Companies: Adaptimmune Therapeutics Institutional Ownership Century Therapeutics Institutional Ownership Metagenomi Institutional Ownership Zura Bio Institutional Ownership Innate Pharma Institutional Ownership Candel Therapeutics Institutional Ownership Invivyd Institutional Ownership Genfit Institutional Ownership Coherus BioSciences Institutional Ownership Compugen Institutional Ownership This page (NASDAQ:ENTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.